Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 238

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Tourette Syndrome and Tic Disorders: A Decade of Progress

SWAIN, JAMES E., SCAHILL, LAWRENCE, LOMBROSO, PAUL J., KING, ROBERT A., LECKMAN, JAMES F.·2007·Journal of the American Academy of Child & Adolescent Psychiatry

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/chi.0b013e318068fbcc

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 208

  1. Abelson, 2005, Sequence variants in SLITRK1 are associated with Tourette's syndrome, Science, 310, 317, 10.1126/science.1116502 · DOI · Paper page
  2. Abuzzahab, 2001, Control of Tourette's syndrome with topiramate, Am J Psychol, 158, 968, 10.1176/appi.ajp.158.6.968 · DOI
  3. Ackermans, 2006, Deep brain stimulation in Tourette's syndrome: two targets?, Mov Disord, 21, 709, 10.1002/mds.20816 · DOI · Paper page
  4. Albin, 2003, Increased ventral striatal monoaminergic innervation in Tourette syndrome, Neurology, 61, 310, 10.1212/01.WNL.0000076181.39162.FC · DOI · Paper page
  5. Alexander, 2004, Testing the prenatal hormone hypothesis of tic-related disorders: gender identity and gender role behavior, Dev Psychopathol, 16, 407, 10.1017/S095457940404458X · DOI
  6. Allen, 2005, Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders, Neurology, 65, 1941, 10.1212/01.wnl.0000188869.58300.a7 · DOI · Paper page
  7. Amat, 2006, Increased number of subcortical hyperintensities on MRI in children and adolescents with Tourette's syndrome, obsessive-compulsive disorder, and attention deficit hyperactivity disorder, Am J Psychiatry, 163, 1106, 10.1176/ajp.2006.163.6.1106 · doi:10.1176/ajp.2006.163.6.1106
  8. Anca, 2004, Ropinirole in Gilles de la Tourette syndrome, Neurology, 62, 1626, 10.1212/01.WNL.0000123111.00324.BF · DOI
  9. Avery, 2000, The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex and improves accuracy in monkeys performing a spatial working memory task, Neuropsychopharmacology, 23, 240, 10.1016/S0893-133X(00)00111-1 · DOI
  10. Awaad, 1999, Tourette syndrome: new treatment options, J Child Neurol, 14, 316, 10.1177/088307389901400508 · DOI
  11. Awaad, 2005, Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome, Mov Disord, 20, 714, 10.1002/mds.20385 · DOI
  12. Banaschewski, 2003, Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents, Dev Med Child Neurol, 45, 700, 10.1111/j.1469-8749.2003.tb00873.x · doi:10.1111/j.1469-8749.2003.tb00873.x
  13. Barbanti, 2004, Migraine and Tourette syndrome, Arch Neurol, 61, 606, 10.1001/archneur.61.4.606-b · doi:10.1001/archneur.61.4.606-b
  14. Baron-Cohen, 1999, The prevalence of Gilles de la Tourette syndrome in children and adolescents with autism: a large scale study, Psychol Med, 29, 1151, 10.1017/S003329179900896X · DOI · Paper page
  15. Biswal, 1998, Abnormal cerebral activation associated with a motor task in Tourette syndrome, AJNR Am J Neuroradiol, 19, 1509
  16. Black, 2000, Response to levodopa challenge in Tourette syndrome, Mov Disord, 15, 1194, 10.1002/1531-8257(200011)15:6<1194::AID-MDS1019>3.0.CO;2-H · DOI
  17. Blair, 2005, Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study, J Am Acad Child Adolesc Psychiatry, 44, 73, 10.1097/01.chi.0000145372.61239.bb · DOI
  18. Bloch, 2005, Caudate volumes in childhood predict symptom severity in adults of Tourette syndrome, Neurology, 65, 1253, 10.1212/01.wnl.0000180957.98702.69 · DOI · Paper page
  19. Bloch, 2006, Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome, Arch Pediatr Adolesc Med, 160, 65, 10.1001/archpedi.160.1.65 · DOI · Paper page
  20. Bloch, 2006, Fine-motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette's syndrome, J Child Psychol Psychiatry, 47, 551, 10.1111/j.1469-7610.2005.01561.x · DOI
  21. Bohlhalter, 2006, Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study, Brain, 129, 2029, 10.1093/brain/awl050 · DOI · Paper page
  22. Bruggeman, 2001, Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study, J Clin Psychiatry, 62, 50, 10.4088/JCP.v62n0111 · DOI · Paper page
  23. Bruun, 1996, Risperidone as a treatment for Tourette's syndrome, J Clin Psychiatry, 57, 29
  24. Bubl, 2006, Aripiprazole in patients with Tourette syndrome, World J Biol Psychiatry, 7, 123, 10.1080/15622970500474770 · DOI
  25. Budman, 2000, Explosive outbursts in children with Tourette's disorder, J Am Acad Child Adolesc Psychiatry, 39, 1270, 10.1097/00004583-200010000-00014 · DOI
  26. Budman, 2001, An open-label study of the treatment efficacy of olanzapine for Tourette's disorder, J Clin Psychiatry, 62, 290, 10.4088/JCP.v62n0412 · DOI
  27. Burd, 1999, Prenatal and perinatal risk factors for Tourette disorder, J Perinat Med, 27, 295
  28. Burd, 2005, Tourette syndrome and learning disabilities, BMC Pediatr, 5, 1, 10.1186/1471-2431-5-34 · DOI
  29. Chappell, 1996, Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls, Biol Psychiatry, 39, 776, 10.1016/0006-3223(95)00221-9 · DOI
  30. Canales, 2000, A measure of striatal function predicts motor stereotypy, Nat Neurosci, 3, 377, 10.1038/73949 · DOI · Paper page
  31. Cardona, 2001, Group A streptococcal infections and tic disorders in an Italian pediatric population, J Pediatr, 135, 71, 10.1067/mpd.2001.110325 · DOI
  32. Carter, 2000, Social and emotional adjustment in children affected with Gilles de la Tourette's syndrome: associations with ADHD and family functioning. Attention deficit hyperactivity disorder, J Child Psychol Psychiatry, 41, 215, 10.1017/S0021963099005156 · DOI · Paper page
  33. Castellanos, 1997, Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose, J Am Acad Child Adolesc Psychiatry, 36, 589, 10.1097/00004583-199705000-00008 · DOI · Paper page
  34. Chae, 2004, A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette's syndrome, Cogn Behav Neurol, 17, 109, 10.1097/01.wnn.0000116253.78804.3a · DOI
  35. Channon, 2003, Real-life-type problem solving in Tourette syndrome, Cogn Behav Neurol, 16, 3, 10.1097/00146965-200303000-00002 · DOI
  36. Chappell, 1996, Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive-compulsive disorder and normal controls, Biol Psychiatry, 39, 776, 10.1016/0006-3223(95)00221-9 · DOI
  37. Cheon, 2004, Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder, Psychiatry Res, 130, 85, 10.1016/j.pscychresns.2003.06.001 · DOI
  38. Church, 2003, Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis, J Neurol Neurosurg Psychiatry, 74, 602, 10.1136/jnnp.74.5.602 · DOI · Paper page
  39. Coffey, 2004, Reexamining tic persistence and tic-associated impairment in Tourette's disorder: findings from a naturalistic follow-up study, J Nerv Ment Dis, 192, 776, 10.1097/01.nmd.0000144696.14555.c4 · DOI
  40. Coffey, 2000, Anxiety disorders and tic severity in juveniles with Tourette's disorder, J Am Acad Child Adolesc Psychiatry, 39, 562, 10.1097/00004583-200005000-00009 · DOI
  41. Cohen, 2002, Computational perspectives on dopamine function in prefrontal cortex, Curr Opin Neurobiol, 12, 223, 10.1016/S0959-4388(02)00314-8 · DOI · Paper page
  42. Cohrs, 2001, Decreased sleep quality and increased sleep related movements in patients with Tourette's syndrome, J Neurol Neurosurg Psychiatry, 70, 192, 10.1136/jnnp.70.2.192 · DOI
  43. Comings, 2001, Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders, Ann N Y Acad Sci, 931, 50, 10.1111/j.1749-6632.2001.tb05773.x · DOI
  44. Crawford, 2005, Tourette's syndrome: performance on tests of inhibition, working memory and gambling, J Child Psychol Psychiatry, 46, 1327, 10.1111/j.1469-7610.2005.01419.x · DOI
  45. Cuker, 2004, Candidate locus for Gilles de la Tourette syndrome/obsessive compulsive disorder/chronic tic disorder at 18q22, Am J Med Genet, 130, 37, 10.1002/ajmg.a.30066 · DOI
  46. Curtis, 2004, Genome scan of Tourette syndrome in a single large pedigree shows some support for linkage to regions of chromosomes 5, 10 and 13, Psychiatr Genet, 14, 83, 10.1097/01.ypg.0000107927.32051.f5 · DOI
  47. Dale, 2005, Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease, J Neuroimmunol, 172, 187, 10.1016/j.jneuroim.2005.10.014 · DOI
  48. Davis, 1998, Childhood caffeine tic syndrome, Pediatrics, 101, E4, 10.1542/peds.101.6.e4 · DOI
  49. Decker, 2003, Episodic neonatal hypoxia evokes executive dysfunction and regionally specific alterations in markers of dopamine signaling, Neuroscience, 117, 417, 10.1016/S0306-4522(02)00805-9 · DOI
  50. Dewing, 2006, Direct regulation of adult brain function by the male-specific factor SRY, Curr Biol, 16, 415, 10.1016/j.cub.2006.01.017 · DOI · Paper page
  51. Diaz-Anzaldua, 2004, Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population, Mol Psychiatry, 9, 272, 10.1038/sj.mp.4001411 · DOI · Paper page
  52. Dion, 2002, Risperidone in the treatment of Tourette syndrome: a double-blind, placebo controlled trial, J Clin Psychopharmacol, 22, 31, 10.1097/00004714-200202000-00006 · DOI · Paper page
  53. Eapen, 2004, Clinical features and associated psychopathology in a Tourette syndrome cohort, Acta Neurol Scand, 109, 255, 10.1046/j.1600-0404.2003.00228.x · DOI
  54. Feigin, 1996, A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder, Neurology, 46, 965, 10.1212/WNL.46.4.965 · DOI
  55. Findley, 2003, Development of the Yale children's global stress index (YCGSI) and its application in children and adolescents with Tourette's syndrome and obsessive-compulsive disorder, J Am Acad Child Adolesc Psychiatry, 42, 450, 10.1097/01.CHI.0000046816.95464.EF · DOI
  56. Gadow, 2002, Tics and psychiatric comorbidity in children and adolescents, Dev Med Child Neurol, 44, 330, 10.1111/j.1469-8749.2002.tb00820.x · DOI
  57. Gadow, 1999, Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder, Arch Gen Psychiatry, 56, 330, 10.1001/archpsyc.56.4.330 · DOI · Paper page
  58. Gaffney, 2002, Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome, J Am Acad Child Adolesc Psychiatry, 41, 330, 10.1097/00004583-200203000-00013 · DOI · Paper page
  59. Garvey, 1999, A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections, Biol Psychiatry, 45, 1564, 10.1016/S0006-3223(99)00020-7 · DOI · Paper page
  60. George, 2001, Transcranial magnetic stimulation (TMS) as a research tool in Tourette syndrome and related disorders, Adv Neurol, 85, 225
  61. Gerard, 2003, Developmental processes and brain imaging studies in Tourette syndrome, J Psychosom Res, 55, 13, 10.1016/S0022-3999(02)00581-0 · DOI
  62. Gilbert, 2003, Tic reduction with pergolide in a randomized controlled trial in children, Neurology, 60, 606, 10.1212/01.WNL.0000044058.64647.7E · DOI
  63. Gilbert, 2000, Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial, Neurology, 54, 1310, 10.1212/WNL.54.6.1310 · DOI
  64. Gonzalez-Burgos, 2005, Functional properties of fast-spiking interneurons and their synaptic connections with pyramidal cells in primate dorsolateral prefrontal cortex, J Neurophysiol, 93, 942, 10.1152/jn.00787.2004 · DOI · Paper page
  65. Graybiel, 2001, The neurobiology of repetitive behaviors: clues to the neurobiology of Tourette syndrome, Adv Neurol, 85, 123
  66. Hallett, 2000, Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction, J Neuroimmunol, 111, 195, 10.1016/S0165-5728(00)00320-9 · DOI · Paper page
  67. Hershey, 2004, Cognitive-pharmacologic functional magnetic resonance imaging in Tourette syndrome: a pilot study, Biol Psychiatry, 55, 916, 10.1016/j.biopsych.2004.01.003 · DOI
  68. Hoekstra, 2004, Neurobiology and neuroimmunology of Tourette's syndrome: an update, Cell Mol Life Sci, 61, 886, 10.1007/s00018-003-3320-4 · DOI
  69. Hoekstra, 2004, Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study, J Clin Psychiatry, 65, 537, 10.4088/JCP.v65n0413 · DOI
  70. Hoekstra, 2004, Relative contribution of attention-deficit hyperactivity disorder, obsessive-compulsive disorder, and tic severity to social and behavioral problems in tic disorders, J Dev Behav Pediatr, 25, 272, 10.1097/00004703-200408000-00007 · DOI
  71. Hoffman, 2004, A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection, J Neurosci, 24, 1780, 10.1523/JNEUROSCI.0887-03.2004 · DOI
  72. Hollenbeck, 2001, Insight and hindsight into Tourette syndrome, Adv Neurol, 85, 363
  73. Holt, 1997, Neurochemical architecture of the human striatum, J Comp Neurol, 384, 1, 10.1002/(SICI)1096-9861(19970721)384:1<1::AID-CNE1>3.0.CO;2-5 · DOI · Paper page
  74. Hong, 2004, Microarray analysis in Tourette syndrome postmortem putamen, J Neurol Sci, 225, 57, 10.1016/j.jns.2004.06.019 · DOI
  75. Hoopes, 1999, Donepezil for Tourette's disorder and ADHD, J Clin Psychopharmacol, 19, 381, 10.1097/00004714-199908000-00019 · DOI
  76. Ivanenko, 2004, Sleep in children with psychiatric disorders, Pediatr Clin North Am, 51, 51, 10.1016/S0031-3955(03)00181-0 · DOI
  77. Izmir, 1999, Cyproterone acetate treatment of Tourette's syndrome, Can J Psychiatry, 44, 710
  78. Jankovic, 2001, Tourette's syndrome, N Engl J Med, 345, 1184, 10.1056/NEJMra010032 · DOI · Paper page
  79. Jeffries, 2002, The functional neuroanatomy of Tourette's syndrome: an FDG PET study III: functional coupling of regional cerebral metabolic rates, Neuropsychopharmacology, 27, 92, 10.1016/S0893-133X(01)00428-6 · DOI
  80. Jin, 2005, Epidemiological survey of Tourette syndrome in children and adolescents in Wenzhou of P.R. China, Eur J Epidemiol, 20, 925, 10.1007/s10654-005-2953-z · DOI
  81. Jog, 1999, Building neural representations of habits, Science, 286, 1745, 10.1126/science.286.5445.1745 · DOI · Paper page
  82. Kadesjo, 2000, Tourette's disorder: epidemiology and comorbidity in primary school children, J Am Acad Child Adolesc Psychiatry, 39, 548, 10.1097/00004583-200005000-00007 · DOI · Paper page
  83. Kalanithi, 2005, Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome, Proc Natl Acad Sci U S A, 102, 13307, 10.1073/pnas.0502624102 · DOI · Paper page
  84. Kastrup, 2005, Treatment of tics in Tourette syndrome with aripiprazole, J Clin Psychopharmacol, 25, 94, 10.1097/01.jcp.0000150229.69124.66 · DOI
  85. Kawikova, 2007, Decreased number of regulatory T cells suggests impaired immune tolerance in children with Tourette syndrome: a preliminary study, Biol Psychiatry, 61, 273, 10.1016/j.biopsych.2006.06.012 · DOI
  86. Kessler, 2002, Tourette syndrome associated with body temperature dysregulation: possible involvement of an idiopathic hypothalamic disorder, J Child Neurol, 17, 738, 10.1177/08830738020170101301 · doi:10.1177/08830738020170101301
  87. Kessler, 2004, Effects of medications on regulation of body temperature of patients with Tourette syndrome, J Child Neurol, 19, 220
  88. Kéri, 2002, Probabilistic classification learning in Tourette syndrome, Neuropsychologia, 40, 1356, 10.1016/S0028-3932(01)00210-X · DOI
  89. Khalifa, 2003, Prevalence of tic disorders and Tourette syndrome in a Swedish school population, Dev Med Child Neurol, 45, 31531, 10.1017/S0012162203000598 · DOI · Paper page
  90. King, 2006, Syncope in children with Tourette's syndrome treated with guanfacine, Mov Disord, 21, 419, 10.1002/mds.20738 · DOI
  91. Kirvan, 2003, Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea, Nat Med, 9, 914, 10.1038/nm892 · DOI · Paper page
  92. Kirvan, 2006, Antibody-mediated neuronal cell signaling in behavior and movement disorders, JNeuroimmunol, 179, 173, 10.1016/j.jneuroim.2006.06.017 · DOI · Paper page
  93. Kompoliti, 1998, Hyperkinetic movement disorders misdiagnosed tics in Gilles de la Tourette syndrome, Mov Disord, 13, 477, 10.1002/mds.870130317 · DOI
  94. Koos, 1999, Inhibitory control of neostriatal projection neurons by GABAergic interneurons, Nat Neurosci, 2, 467, 10.1038/8138 · DOI · Paper page
  95. Kostanecka-Endress, 2003, Disturbed sleep in children with Tourette syndrome: a polysomnographic study, J Psychosom Res, 55, 23, 10.1016/S0022-3999(02)00602-5 · DOI
  96. Krauss, 2002, Head injury and posttraumatic movement disorders, Neurosurgery, 50, 927
  97. Kurlan, 2002, The behavioral spectrum of tic disorders: a community-based study, Neurology, 59, 414, 10.1212/WNL.59.3.414 · DOI · Paper page
  98. Kwak, 2003, Premonitory sensory phenomenon in Tourette's syndrome, Mov Disord, 18, 1530, 10.1002/mds.10618 · DOI · Paper page
  99. Kwak, 2000, Botulinum toxin in the treatment of tics, Arch Neurol, 57, 1190, 10.1001/archneur.57.8.1190 · DOI · Paper page
  100. Kwak, 2003, Migraine headache in patients with Tourette syndrome, Arch Neurol, 60, 1595, 10.1001/archneur.60.11.1595 · DOI
  101. Leckman, 2002, Tourette's syndrome, Lancet, 360, 1577, 10.1016/S0140-6736(02)11526-1 · DOI · Paper page
  102. Leckman, 2005, Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome, Biol Psychiatry, 57, 667, 10.1016/j.biopsych.2004.12.004 · DOI · Paper page
  103. Leckman, 2003, Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome, Am J Med Genet B Neuropsychiatr Genet, 116, 60, 10.1002/ajmg.b.10001 · DOI
  104. Leckman, 2006, Tourette syndrome: a relentless drumbeat, J Child Psychol Psychiatry, 47, 537, 10.1111/j.1469-7610.2006.01620.x · DOI
  105. Leckman, 1998, Course of tic severity in Tourette syndrome: the first two decades, Pediatrics, 102, 14, 10.1542/peds.102.1.14 · DOI · Paper page
  106. Lin, 2006, Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder, J Child Psychol Psychiatry, 48, 157, 10.1111/j.1469-7610.2006.01687.x · DOI · Paper page
  107. Lin, 2002, Assessment of symptom exacerbations in a longitudinal study of children with Tourette syndrome or obsessive-compulsive disorder, J Am Acad Child Adolescent Psychiatry, 41, 1070, 10.1097/00004583-200209000-00007 · DOI
  108. Lipinski, 1997, Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide, Mov Disord, 12, 402, 10.1002/mds.870120320 · DOI
  109. Loiselle, 2003, Antistreptococcal, neuronal, and nuclear antibodies in Tourette syndrome, Pediatr Neurol, 28, 119, 10.1016/S0887-8994(02)00507-6 · DOI
  110. Ludolph, 2006, Grey-matter abnormalities in boys with Tourette syndrome: magnetic resonance imaging study using optimised voxel-based morphometry, Br J Psychiatry, 188, 484, 10.1192/bjp.bp.105.008813 · DOI
  111. Luo, 2004, Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections, Pediatrics, 113, e578, 10.1542/peds.113.6.e578 · DOI
  112. Maia, 1999, Relationship between obsessive-compulsive disorders and diseases affecting primarily the basal ganglia, Rev Hosp Clin Fac Med Sao Paulo, 54, 213, 10.1590/S0041-87811999000600008 · DOI
  113. Mahone, 2001, Executive function in fluency and recall measures among children with Tourette syndrome or ADHD, J Int Neuropsychol Soc, 7, 102, 10.1017/S1355617701711101 · DOI
  114. Malone, 2001, Olanzapine versus haloperidol in children with autistic disorder: an open pilot study, J Am Acad Child Adolesc Psychiatry, 40, 887, 10.1097/00004583-200108000-00009 · DOI · Paper page
  115. Mantel, 2004, Nutritional supplements and complementary/alternative medicine in Tourette syndrome, J Child Adolesc Psychopharmacol, 14, 582, 10.1089/cap.2004.14.582 · DOI
  116. Marras, 2001, Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial, Neurology, 56, 605, 10.1212/WNL.56.5.605 · DOI · Paper page
  117. Marsh, 2004, Habit learning in Tourette syndrome: a translational neuroscience approach to a developmental psychopathology, Arch Gen Psychiatry, 61, 1259, 10.1001/archpsyc.61.12.1259 · DOI
  118. Marsh, 2005, Perceptual-motor skill learning in Gilles de la Tourette syndrome. Evidence for multiple procedural learning and memory systems, Neuropsychologia, 43, 1456, 10.1016/j.neuropsychologia.2004.12.012 · DOI
  119. Mathews, 2006, Association between maternal smoking and increased symptom severity in Tourette's syndrome, Am J Psych, 163, 1066, 10.1176/ajp.2006.163.6.1066 · DOI
  120. Mathews, 2004, Genetic studies of neuropsychiatric disorders in Costa Rica: a model for the use of isolated populations, Psychiatr Genet, 14, 13, 10.1097/00041444-200403000-00003 · DOI
  121. McDougle, 2002, Case series: use of ziprasidone for maladaptive symptoms in youths with autism, J Am Acad Child Adolesc Psychiatry, 41, 921, 10.1097/00004583-200208000-00010 · DOI · Paper page
  122. McMahon, 2003, Children at familial risk for Tourette's disorder: child and parent diagnoses, Am J Med Genet B Neuropsychiatr Genet, 121, 105, 10.1002/ajmg.b.20065 · DOI
  123. Mell, 2005, Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder, Pediatrics, 116, 56, 10.1542/peds.2004-2058 · DOI · Paper page
  124. Mercadante, 1997, Vocal tics in Sydenham's chorea, J Am Acad Child Adolesc Psychiatry, 36, 305, 10.1097/00004583-199703000-00007 · DOI
  125. Merette, 2000, Significant linkage for Tourette syndrome in a large French Canadian family, Am J Hum Genet, 67, 1008, 10.1086/303093 · DOI
  126. Mink, 2006, Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs, Adv Neurol, 99, 89
  127. Mink, 2006, Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome, Mov Disord, 21, 1831, 10.1002/mds.21039 · DOI · Paper page
  128. Moll, 1999, Deficient motor control in children with tic disorder: evidence from transcranial magnetic stimulation, Neurosci Lett, 272, 37, 10.1016/S0304-3940(99)00575-3 · DOI
  129. Morshed, 2001, Antibodies against striatal, nuclear, cytoskeletal and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders, Biol Psychiatry, 50, 566, 10.1016/S0006-3223(01)01096-4 · DOI
  130. Muller, 2004, Anti-inflammatory therapy with a COX-2 inhibitor in Tourette's syndrome, Inflammopharmacology, 12, 271, 10.1163/1568560042342338 · DOI
  131. Muller, 2001, Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome, Psychiatry Res, 101, 187, 10.1016/S0165-1781(01)00215-3 · DOI
  132. Muller, 2004, Mycoplasma pneumoniae infection and Tourette's syndrome, Psychiatry Res, 129, 119, 10.1016/j.psychres.2004.04.009 · DOI
  133. Muller, 2000, Tourette's syndrome and Mycoplasma pneumoniae infection, Am J Psychiatry, 157, 481, 10.1176/appi.ajp.157.3.481-a · DOI
  134. Muller, 2003, Disturbed monitoring and response inhibition in patients with Gilles de la Tourette syndrome and co-morbid obsessive compulsive disorder, Behav Neurol, 14, 29, 10.1155/2003/832906 · DOI
  135. Nicolson, 2005, A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder, J Am Acad Child Adolesc Psychiatry, 44, 640, 10.1097/01.chi.0000163279.39598.44 · DOI
  136. Nestadt, 2002, Obsessive-compulsive disorder: defining the phenotype, J Clin Psychiatry, 63, 5
  137. Onofrj, 2000, Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double blind cross over study vs. low-dose pimozide, J Neurol, 247, 443, 10.1007/s004150070173 · DOI
  138. Padala, 2005, Aripiprazole for the treatment of Tourette's disorder, J Clin Psychiatry, 7, 296
  139. Pappert, 2003, Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome, Neurology, 61, 936, 10.1212/01.WNL.0000086370.10186.7C · DOI · Paper page
  140. Pauls, 2003, An update on the genetics of Gilles de la Tourette syndrome, J Psychosom Res, 55, 7, 10.1016/S0022-3999(02)00586-X · DOI
  141. Perrin, 2004, Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children?, Arch Pediatr Adolesc Med, 158, 848, 10.1001/archpedi.158.9.848 · DOI
  142. Peterson, 1998, The temporal dynamics of tics in Gilles de la Tourette syndrome, Biol Psychiatry, 44, 1337, 10.1016/S0006-3223(98)00176-0 · DOI · Paper page
  143. Peterson, 1998, A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome, J Clin Psychopharmacol, 18, 324, 10.1097/00004714-199808000-00013 · DOI
  144. Piacentini, 2001, Behavioral treatments for Tourette syndrome in tic disorders: state of the art, Adv Neurol, 85, 319
  145. Plessen, 2004, Altered interhemispheric connectivity in individuals with Tourette syndrome, Am J Psychiatry, 161, 2028, 10.1176/appi.ajp.161.11.2028 · DOI
  146. Porta, 2004, Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A, Neurol Sci, 24, 420, 10.1007/s10072-003-0201-4 · DOI
  147. Riedel, 1998, Lyme disease presenting as Tourette's syndrome, Lancet, 351, 418, 10.1016/S0140-6736(05)78357-4 · DOI
  148. Robertson, 2003, Diagnosing Tourette syndrome. Is it a common disorder?, J Psychosom Res, 55, 3, 10.1016/S0022-3999(02)00580-9 · DOI
  149. Robertson, 1999, The Tourette syndrome diagnostic confidence index: development and clinical associations, Neurology, 53, 2108, 10.1212/WNL.53.9.2108 · DOI · Paper page
  150. Sallee, 2000, Ziprasidone treatment of children and adolescents with Tourette's disorder, J Am Acad Child Adolesc Psychiatry, 39, 292, 10.1097/00004583-200003000-00010 · DOI · Paper page
  151. Sallee, 1997, Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder, Am J Psychiatry, 154, 1057, 10.1176/ajp.154.8.1057 · DOI · Paper page
  152. Sanberg, 1998, Treatment of Tourette syndrome with mecamylamine, Lancet, 352, 705, 10.1016/S0140-6736(05)60822-7 · DOI
  153. Sandor, 2003, Pharmacological management of tics in patients with TS, J Psychosom Res, 55, 41, 10.1016/S0022-3999(03)00060-6 · DOI
  154. Saunders-Pullman, 1999, Pediatric movement disorders, Child Adolesc Psychiatr Clin N Am, 8, 747, 10.1016/S1056-4993(18)30151-2 · DOI
  155. Scahill, 2005, Adding psychosocial therapy to methylphenidate may not improve its effectiveness in stimulant responsive children with ADHD, Evid Based Ment Health, 8, 9, 10.1136/ebmh.8.1.9 · DOI
  156. Scahill, 2001, A placebo-controlled study of guanficine in the treatment of children with tic disorders and attention deficit hyperactivity disorder, Am J Psychiatry, 158, 1067, 10.1176/appi.ajp.158.7.1067 · DOI · Paper page
  157. Scahill, 2006, Contemporary assessment and pharmacotherapy of Tourette syndrome, NeuroRx, 3, 192, 10.1016/j.nurx.2006.01.009 · DOI · Paper page
  158. Scahill, 2001, Thermal sensitivity in Tourette syndrome: preliminary report, Percept Mot Skills, 92, 419, 10.2466/pms.2001.92.2.419 · DOI
  159. Scahill, 2005, Public health significance of tic disorders in children and adolescents, Adv Neurol, 96, 240
  160. Schultz, 1998, Visual-motor integration functioning in children with Tourette syndrome, Neuropsychology, 12, 134, 10.1037/0894-4105.12.1.134 · DOI
  161. Segawa, 2003, Neurophysiology of Tourette's syndrome: pathophysiological considerations, Brain Dev, 25, S62, 10.1016/S0387-7604(03)90011-8 · DOI
  162. Serra-Mestres, 2004, Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study, Acta Psychiatr Scand, 109, 140, 10.1111/j.0001-690X.2004.00214.x · DOI · Paper page
  163. Serrien, 2002, Movement control of manipulative tasks in patients with Gilles de la Tourette syndrome, Brain, 125, 290, 10.1093/brain/awf024 · DOI
  164. Serrien, 2005, Motor inhibition in patients with Gilles de la Tourette syndrome: functional activation patterns as revealed by EEG coherence, Brain, 128, 116, 10.1093/brain/awh318 · DOI · Paper page
  165. Silver, 2001, Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome, J Am Acad Child Adolesc Psychiatry, 35, 1631, 10.1097/00004583-199612000-00015 · DOI
  166. Silver, 2001, Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder, J Am Acad Child Adolesc Psychiatry, 40, 1103, 10.1097/00004583-200109000-00020 · DOI
  167. Simonic, 1998, Identification of genetic markers associated with Gilles de la Tourette syndrome in an Afrikaner population, Am J Hum Genet, 63, 839, 10.1086/302002 · DOI
  168. Singer, 1998, Antibodies against human putamen in children with Tourette syndrome, Neurology, 50, 1618, 10.1212/WNL.50.6.1618 · DOI · Paper page
  169. Singer, 2005, Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls, Neurology, 65, 1701, 10.1212/01.wnl.0000183223.69946.f1 · DOI
  170. Singer, 2002, Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET, Am J Psychiatry, 159, 1329, 10.1176/appi.ajp.159.8.1329 · DOI · Paper page
  171. Singer, 2001, Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial, Neurology, 56, 599, 10.1212/WNL.56.5.599 · DOI
  172. Snider, 2002, Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations, Pediatrics, 110, 331, 10.1542/peds.110.2.331 · DOI · Paper page
  173. Snider, 2004, PANDAS: current status and directions for research, Mol Psychiatry, 9, 900, 10.1038/sj.mp.4001542 · DOI · Paper page
  174. Spencer, 1998, Disentangling the overlap between Tourette's disorder and ADHD, J Child Psychol Psychiatry, 39, 1037, 10.1111/1469-7610.00406 · doi:10.1111/1469-7610.00406 · Paper page
  175. Spencer, 2001, Tourette disorder and ADHD, Adv Neurol, 85, 57
  176. Stamenkovic, 2000, Effective open-label treatment of Tourette disorder with olanzapine, Int Clin Psychopharmacol, 15, 23, 10.1097/00004850-200015010-00003 · DOI
  177. State, 2003, Epigenetic abnormalities associated with a chromosome 18q(21-22) and a Gilles de la Tourette syndrome phenotype, Proc Natl Acad Sci U S A, 100, 4684, 10.1073/pnas.0730775100 · DOI
  178. Stephens, 2004, Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome-a pilot study, J Child Adolesc Psychopharmacol, 14, 255, 10.1089/1044546041648959 · DOI
  179. Stern, 2000, A functional neuroanatomy of tics in Tourette syndrome, Arch Gen Psychiatry, 57, 741, 10.1001/archpsyc.57.8.741 · DOI · Paper page
  180. Storch, 2005, Reliability and validity of the Yale Global Tic Severity Scale, Psychol Assess, 17, 486, 10.1037/1040-3590.17.4.486 · DOI · Paper page
  181. Sukhodolsky, 2005, Adaptive, emotional, and family functioning of children with obsessive-compulsive disorder and comorbid attention deficit hyperactivity disorder, Am J Psychiatry, 162, 1125, 10.1176/appi.ajp.162.6.1125 · DOI
  182. Sukhodolsky, 2004, Cognitive-behavioral therapy for anger in children and adolescents: a meta-analysis, Aggression Violent Behav, 9, 247, 10.1016/j.avb.2003.08.005 · DOI · Paper page
  183. Sukhodolsky, 2003, Disruptive behavior in children with Tourette's syndrome: association with ADHD comorbidity, tic severity, and functional impairment, J Am Acad Child Adolesc Psychiatry, 42, 98, 10.1097/00004583-200301000-00016 · DOI · Paper page
  184. Swain, 2003, Tourette's syndrome in children, Curr Treat Options Neurol, 5, 299, 10.1007/s11940-003-0036-6 · DOI
  185. Swedo, 1998, Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases, Am J Psychiatry, 155, 264, 10.1176/ajp.155.2.264 · DOI · Paper page
  186. Swerdlow, 2000, Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon, Behav Pharmacol, 11, 185, 10.1097/00008877-200006000-00002 · DOI · Paper page
  187. Swerdlow, 2001, Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an “fMRI-friendly” startle paradigm, Biol Psychiatry, 50, 578, 10.1016/S0006-3223(01)01164-7 · DOI · Paper page
  188. Tang, 2005, Blood gene expression profiling of neurologic diseases: a pilot microarray study, Arch Neurol, 62, 210, 10.1001/archneur.62.2.210 · DOI
  189. Taylor, 2002, An animal model of Tourette's syndrome, Am J Psychiatry, 159, 657, 10.1176/appi.ajp.159.4.657 · DOI
  190. Toren, 1999, Odansetron treatment in patients with Tourette's syndrome, Int Clin Psychopharmacol, 14, 373, 10.1097/00004850-199911000-00008 · DOI
  191. Tourette Syndrome Association International Consortium for Genetics, 1999, A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome, Am J Hum Genet, 65, 1428, 10.1086/302613 · DOI · Paper page
  192. Tucker, 1996, A putative poststreptococcal case of ocd with chronic tic disorder, not otherwise specified, J Am Acad Child Adolesc Psychiatry, 35, 1684, 10.1097/00004583-199612000-00022 · DOI
  193. van der Linden, 2002, Successful treatment of tics with bilateral internal pallidum (GPi) stimulation in a 27-year-old male patient with Gilles de la Tourette's syndrome, Mov Disord, 17, 1130
  194. Vandewalle, 1999, Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus, Lancet, 353, 724, 10.1016/S0140-6736(98)05964-9 · DOI · Paper page
  195. Verdellen, 2004, Exposure with response prevention versus habit reversal in Tourette's syndrome: a controlled study, Behav Res Ther, 42, 501, 10.1016/S0005-7967(03)00154-2 · DOI · Paper page
  196. Verkerk, 2003, CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder, Genomics, 82, 1, 10.1016/S0888-7543(03)00097-1 · DOI · Paper page
  197. Visser-Vandewalle, 2003, Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases, J Neurosurg, 99, 1094, 10.3171/jns.2003.99.6.1094 · DOI · Paper page
  198. Visser-Vandewalle, 2004, Deep brain stimulation in movement disorders. The applications reconsidered, Acta Neurol Belg, 104, 33
  199. Wang, 2003, Tourette's syndrome in Taiwan: an epidemiological study of tic disorders in an elementary school at Taipei County, Brain Dev, 25, S29, 10.1016/S0387-7604(03)90005-2 · DOI
  200. Wendlandt, 2001, Striatal antibodies in children with Tourette's syndrome: multivariate discriminant analysis of IgG repertoires, J Neuroimmunol, 119, 106, 10.1016/S0165-5728(01)00370-8 · DOI

200 of 208 shown

Cited by

See all 238

Metadata

Authors
SWAIN, J. E., SCAHILL, L., LOMBROSO, P. J., KING, R. A., & LECKMAN, J. F.
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
2007-08
Volume
46
Issue
8
Pages
947-968
ISSN
0890-8567 (ISSN-L)
OpenAlex
W2021194895
Cited by
238
References
29
FWCI
22.41
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tourette Syndrome and Tic Disorders: A Decade of Progress. https://app.cochat.ai/papers/10.1097/chi.0b013e318068fbcc
The paper
SWAIN, J. E., SCAHILL, L., LOMBROSO, P. J., KING, R. A., & LECKMAN, J. F. (2007). Tourette Syndrome and Tic Disorders: A Decade of Progress. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1097/chi.0b013e318068fbcc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.